CORD-19:c654596857bce9cdd64ffc51842048643107348c / 384118-384538 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3289","span":{"begin":0,"end":420},"obj":"Sentence"},{"id":"T40822","span":{"begin":0,"end":420},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI."}

{"project":"Epistemic_Statements","denotations":[{"id":"T496","span":{"begin":0,"end":420},"obj":"Epistemic_statement"}],"text":"In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T289","span":{"begin":0,"end":420},"obj":"Sentence"}],"text":"In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI."}